FOR IMMEDIATE RELEASE
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand Masterclass
Bangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.

Clinical Excellence Backed by Data
According to Singderm’s official brochure:
92.7% efficacy at 12 months measured by Wrinkle Severity Rating Scale (WSRS)
Median pain score of 2.0 (0-10 scale) in independent assessments
100% nodule-free results across 3 injection sites (China, Italy, Brazil)
Dr. Worawat Nolah emphasized:
"Singderm’s 24mg/mL HA concentration and SingLink™ cross-linking technology deliver unmatched stability – crucial for natural outcomes in dynamic areas like lips and nasolabial folds."
KOLs Verify Real-World Performance
ChalidaornPinNy on longevity:
"No lumps or migration after 6 months – exactly as the brochure promises!"HackAnantaya on comfort:
"The BD Hylok™ syringe made injections seamless – I felt only mild pressure."ThantayaThuranuch on versatility:
"From under-eyes to temples, Singderm held shape identically."
Why Singderm Stands Apart
Patented Technology
SingLink™ Cross-Linking : Ensures 12-month durability
StabilityTech™ Formula : Prevents migration in mobile zones
Safety Assurance
Non-Animal HA (Streptococcus fermentation, JP/EP certified)
Terminal Sterilization at 121°C
Enhanced Experience
BD Hylok™ Prefilled Syringe with integrated Luer Lock
0.3% Lidocaine for minimized pain
Global Compliance & Availability
Certified under CE 2292, NMPA, and ISO 13485, Singderm is available worldwide via distributors like SingdermThailand. As stated by Dr. Lucia Linde
"Perfect for plumping lips and full-face rejuvenation – I love this product!"
-
singclean | 2025-08-19
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2025-08-19
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2025-08-19
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.